Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
John C.I. Constant
Institution:
PRA Health Sciences
Observed institution:
PRA Health Sciences
OpenAlex ID:
A5065720959
Dianhydrogalactitol in bevacizumab-refractory GBM: Further analysis of a phase 1-2 trial.
2018
·
Kent C. Shih
, Manish R. Patel
, et al.
·
Journal of Clinical Oncology
·
3
Show more works
View as search
Works count:
1
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type
